326334

Intracoronary Pharmacotherapy (Verapamil-Epinephrine-Adenosine) for Prevention of No Reflow during Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocar

Article

Last updated: 05 Jan 2025

Subjects

-

Tags

Applied and Basic Science.

Abstract

Background: When the TIMI flow is less than 3 or, in the instance of a flow of 3, when the MBG is 0 or 1, no reflow is detected (in the absence of evident vessel dissection, obstruction or distal vessel embolic cutoff). According to the TIMI flow count, the flow in the coronaries may be graded as 0 (no flow), 1 (penetration without perfusion), 2, or 3 (partial perfusion) (complete perfusion). Patients and Methods: This research included 128 individuals who had acute ST elevation myocardial infarction during the first 24 hours of experiencing symptoms and were treated at Wadi El-Nile and Ain Shams university hospitals between the years 2022 and 2023.. Results: The epinephrine group, followed by the verapamil group, followed by the adenosine group, followed by the control group, had the best TIMI flow grade and MBG scores. After taking the medicines, there was no significant difference in the TIMI thrombus grade across the 4 groups. ST segment resolution varied quantitatively across the 4 groups, but there was no statistically significant difference.. Conclusion: According to the available data, epinephrine, verapamil, and adenosine are safe and efficient in avoiding no-reflow in patients with ST Elevation Myocardial Infarction during PPCI, with epinephrine performing best, followed by verapamil, then adenosine

DOI

10.21608/bjas.2023.224991.1213

Keywords

Verapamil-Epinephrine-Adenosine Intracoronary Pharmacotherapy, No reflow, Primary percutaneous coronary intervention, ST elevation myocardial infarction

Authors

First Name

Ahmed

Last Name

Bendary

MiddleName

-

Affiliation

Cardiovascular Medicine, Faculty of Medicine, Benha University

Email

ahmedbendary55@gmail.com

City

-

Orcid

-

First Name

Mohamed

Last Name

Salem

MiddleName

-

Affiliation

Cardiovascular Medicine, Faculty of Medicine, Benha University

Email

mohamedabdo88@gmail.com

City

-

Orcid

-

First Name

Amr

Last Name

El-Sayed

MiddleName

-

Affiliation

Cardiovascular Medicine, Faculty of Medicine, Benha University

Email

amrabdel-mordy@gmail.com

City

-

Orcid

-

First Name

Haitham

Last Name

Al-Kady

MiddleName

-

Affiliation

Cardiovascular Medicine, Faculty of Medicine, Benha University

Email

haithamal-kady@gmail.com

City

-

Orcid

-

First Name

Ayman

Last Name

Khamis

MiddleName

-

Affiliation

Cardiovascular Medicine, Faculty of Medicine, Benha University

Email

aymanhazem1994@gmail.com

City

Cairo

Orcid

-

First Name

Hany

Last Name

Ebaid

MiddleName

-

Affiliation

Cardiovascular Medicine, Faculty of Medicine, Benha University

Email

hanyebaid@gmail.com

City

-

Orcid

-

Volume

8

Article Issue

8

Related Issue

43071

Issue Date

2023-08-01

Receive Date

2023-08-03

Publish Date

2023-08-29

Page Start

1

Page End

11

Print ISSN

2356-9751

Online ISSN

2356-976X

Link

https://bjas.journals.ekb.eg/article_326334.html

Detail API

https://bjas.journals.ekb.eg/service?article_code=326334

Order

1

Type

Original Research Papers

Type Code

1,647

Publication Type

Journal

Publication Title

Benha Journal of Applied Sciences

Publication Link

https://bjas.journals.ekb.eg/

MainTitle

Intracoronary Pharmacotherapy (Verapamil-Epinephrine-Adenosine) for Prevention of No Reflow during Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocar

Details

Type

Article

Created At

28 Dec 2024